Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track CRDL with free AI briefings, catalyst countdowns, and dilution alerts.

CRDL

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$21.4M Cash on Hand

10.8mo Cash Runway

1.8% Short Interest

🧪 Upcoming Trial Catalysts

2026-09-21 · Phase 3 — Recruiting — CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

📊 Drug Pipeline

Drug	Indication	Phase	Status
CardiolRx	Recurrent Pericarditis	PHASE3	RECRUITING
Cannabidiol, pharmaceutically produced w	COVID-19	PHASE2	TERMINATED

💰 Cash Runway & Dilution Risk

CRDL holds $21.4M in cash and burns about $6M/quarter from operations, giving an estimated runway of 10.8 months.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for CRDL free →

Get the full CRDL picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for CRDL and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z